How to make your money go further

Tristel (AIM: TSTL) – cracking results and positive outlook bring out more upgrades

12/10/2015 · Tristel (TSTL) 

The AIM quoted manufacturer of infection prevention and contamination control products, announces excellent ‘audited’ results for the year ahead of expectations with a resulting upgrade from the house broker. 

The Group’s proprietary chlorine dioxide formulation and the Company addresses three distinct markets:

- The Human Healthcare market (hospital infection prevention - via the Tristel brand) represents 85% of Group sales
- The Contamination Control market (control of contamination in critical environments - via the Crystel brand)
- The Animal Healthcare market (veterinary practice infection prevention - via the Anistel brand)


Tristel’s proprietary chlorine dioxide chemistry has two defining features: first, it kills bacterial spores very quickly; second, it is safe to use.  As a consequence, Tristel’s surface disinfectants provide the most effective stratagem to control Clostridium difficile, one of the most problematic pathogens in hospitals. 

For the year ending 30th June 2015 turnover was up 14% to £15.3m, pre-tax profit up 44% to £2.6m and basic earnings per share up a whopping 67% to 5.44p. The full year dividend per share was increased to 5.72p (2014: 1.62p) and included a special…

Sign up and read the full article

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

Investment news & insights

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Investor's Champion Premium Content

Subscribers to our Premium Content receive priority notification by email of newly published research. Premium Content costs as little as £3.20 per research note.

More on Premium Content

More on Tristel

Investor’s Champion podcast: ISA time

03/04/2019 · Podcasts
It’s ISA time. With just two days to go before the ISA deadline, it’s a good…

Tristel gains key approval in China

01/04/2019 · Portfolio Flash News
Tristel has its sights firmly set on China as a crucial market for long-term revenue growth.…

Tristel looks to China for more growth

13/03/2019 · Portfolio
The value of Tristel’s medical device decontamination products are highlighted by the fact that the company…

6 quality AIM shares for your portfolio

15/10/2015 · Blog
Our Blog this week has featured results and updates from a number of wonderful small…

Tristel (AIM: TSTL) – cracking results and positive outlook bring out more upgrades

12/10/2015 · Blog
The AIM quoted manufacturer of infection prevention and contamination control products, announces excellent ‘audited’ results for…

More from the Blog

The Genius of Guinness

09/04/2019 · Diageo PLC

Tesla tanks on weaker than expected demand

04/04/2019 · Tesla

March 2019 AIM new arrivals - another poor month for newcomers and plenty of departures